Feasibility of split-course stereotactic ablative radiotherapy for oligometastases
Sign Up to like & getrecommendations! Published in 2018 at "Japanese Journal of Clinical Oncology"
DOI: 10.1093/jjco/hyy062
Abstract: Split-course stereotactic ablative radiotherapy (SABR) appeared to achieve favorable toxicity profiles and local control outcomes comparable with those of continuous SABR in the patients with oligometastases. read more here.
Keywords: ablative radiotherapy; stereotactic ablative; course stereotactic; split course ... See more keywords